Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury

Life Sciences

Volumn 72, Issue 9, 2003, Pages 1073-1083

  Pan, Tianhong ^a,b   Fei, Jian ^c   Zhou, Xiaoda ^b   Jankovic, Joseph ^a   Le, Weidong ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

1 methyl 4 phenylpyridinium; Dopamine transporter; Green tea; Neuroprotection; Parkinson's disease; Polyphenols

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE TRANSPORTER; MAZINDOL; PLASMID DNA; POLYPHENOL DERIVATIVE; TRITIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG ISOLATION; EMBRYO; EMBRYO CELL; GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; RAT; TEA;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMAL; CHO CELLS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HAMSTERS; MALE; MAZINDOL; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; PHENOLS; PLANT EXTRACTS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPTOSOMES; TEA; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0242432638     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02347-0     Document Type: Article

References (27)

1. Abbas N., Lucking C.B., Ricard S., Durr A., Brice A. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's disease genetics study group and the European consortium on genetic susceptibility in Parkinson's disease. Human Molecular Genetics. 8(4):1999;567-574.
2. Oliveri R.L., Zappia M., Annesi G., Bosco D., Quattrone A. The parkin gene is not involved in late-onset Parkinson's disease. Neurology. 57(2):2001;359-362.
3. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins: an etiologic study. JAMA. 281(4):1999;341-346.
4. Langston J.W. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Annals of Neurology. 44(3 Suppl.):1998;S45-S52.
5. Chan D.K.Y., Woo J., Ho S.C., Pang C.P., Law L.K., Kay R. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. Journal of Neurology, Neurosurgery and Psychiatry. 65(5):1998;781-784.
6. +, oxidant and specific neurotoxins shares the common molecular mechanism. Journal of Neurochemistry. 76(4):2001;1010-1021.
7. Gerlach M., Gotz M., Dirr A., Kupsch A., Janetzky B., Oertel W., Riederer P. Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin. Neurochemistry International. 28(1):1996;41-49.
8. Kim J.W., Kim D.H., Kim S.H., Cha J.K. Association of the dopamine transporter gene with Parkinson's disease in Korean patients. Journal of Korean Medical Sciences. 15(4):2000;449-451.
9. Bezard E., Gross C.E., Fournier M.C., Dovero S., Bloch B., Jaber M. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Experimental Neurology. 155(2):1999;268-273.
10. Ricaurte G.A., Langston J.W., Delanney L.E., Irwin I., Brooks J.D. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum. Neuroscience Letters. 59:1985;259-264.
11. Liu Z., Wang Y., Zhang J., Ding J., Guo L., Cui D., Fei J. Orphanin FQ: an endogenous antagonist of rat brain dopamine transporter. Neuroreport. 12(4):2001;699-702.
12. Chen N.H., Ding J.H., Wang Y.L., Reith M.E.A. Potential misconceptions in dopamine transporter assays arising from the binding of [125I]RTI-121 to filters: effect of ions and cocaine. Journal of Neuroscience Methods. 75(2):1997;179-186.
13. Zhang L., Coffey L.L., Reith M.E.A. Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochemical Pharmacology. 53(5):1997;677-688.
14. Ptak L.R., Hart K.R., Lin D., Carvey P.M. Isolation and manipulation of rostral mesencephalic tegmental progenitor cells from rat. Cell Transplantation. 4(3):1995;335-342.
15. Pifl C., Giros B., Caron M.G. Dopamine transporter expression confers cytotoxicity to low dosed of the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. Journal of Neuroscience. 13:1993;4246-4253.
16. Le W.D., Rowe D., Xie W.J., Ortiz I., He Y., Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. Journal of Neuroscience. 21(21):2001;8447-8455.
17. Giros B., Mestikawy S., Bertland L., Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Letters. 295:1991;149-154.
18. Kilty J.E., Lorang D., Amara S.G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science. 254:1991;578-579.
19. + transport. Synapses. 15(1):1993;58-62.
20. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proceedings of the National Academy of Sciences of the United States of America. 82:1985;2173-2177.
21. Jaber M., Jones S., Giros B., Caron M.G. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disorders. 12(5):1997;629-633.
22. +) via impairment of energy metabolism. Neurochemistry International. 35(5):1999;393-403.
23. Levites Y., Weinreb O., Maor G., Youdim M.B.H., Mandel S. Green tea polyphenols (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. Journal of Neurochemistry. 78(5):2001;1073-1082.
24. 3H)-(-)-epigallocatechin gallate, a cancer preventive tea polyphenol in mouse tissue. Carcinogenesis. 19(10):1998;1771-1776.
25. Nakagawa K., Miyazawa T. Absorption and distribution of tea catechin, (-)-Epigallocatechin-3-Gallate, in the rat. Journal of Nutritional Science and Vitaminology. 43:1997;679-684.
26. Serafini M., Ghiselli A., Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. European Journal of Clinical Nutrition. 50:1996;28-32.
27. Sano M., Takahashi Y., Yoshino K., Shimoi K., Nakamura Y., Tomita I., Oguni I., Konomoto H. Effect of tea (Camellia Sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green tea and black tea feeding. Biological and Pharmaceutical Bulletin. 18:1995;1006-1008.